Dr. Pendurthi is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
3600 Fairview St
Bethlehem, PA 18017Phone+1 610-882-0199Fax+1 610-882-2814
Education & Training
- Virginia Commonwealth University Health SystemResidency, Surgery, 1991 - 1995
- St Elizabeth's Medical Center/Lemuel Shattuck HospitalInternship, Transitional Year, 1990 - 1991
- Osmania Medical College NTR UHSClass of 1979
Certifications & Licensure
- NJ State Medical License 1999 - 2025
- PA State Medical License 1995 - 2024
- American Board of Surgery Surgery
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification NextGen Ambulatory EHR, NextGen Healthcare, 2011-2013
Publications & Presentations
PubMed
- 15 citationsPreoperative chemotherapy of chemoradiotherapy for the treatment of adenocarcinoma of the pancreas and ampulla of VaterJohn P. Hoffman, Harry S. Cooper, Nancy A. Young, T. K. Pendurthi
Journal of Hepato-Biliary-Pancreatic Surgery. 1998-11-01 - Management of exocrine carcinoma of the pancreas.John P. Hoffman, Tribhuvan K. Pendurthi, Johnson De
Cancer Treatment and Research. 1998-01-01 - 7 citationsChimeric B72.3 mouse/human (IgG1) antibody directs the lysis of tumor cells by lymphokine-activated killer cells.F. J. Primus, T. K. Pendurthi, P Hutzell, S Kashmiri, D C Slavin
Cancer Immunology, Immunotherapy. 1990-01-01
Professional Memberships
- Member
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: